Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis
Research that provided much of the foundation for the development of CAR-T cell therapy, the first-generation cell therapy approach currently in clinical development, for lupus was funded in part by the Lupus Research Alliance (LRA) Lupus Innovation Award grant in 2014 to Marko Radic, Ph.D. from the University of Tennessee Health Science Center. Lupus Therapeutics, and… Read More